开幕致辞

难治性高血压专家共识解读

从医生的角度谈难治性高血压

老年高血压与衰弱：探索相关性、国际诊疗进展与实践策略

肥胖相关高血压

老年难治性高血压干预策略

难治性高血压依从性评估策略

病例分享

讨论

总结

心脏超声与心脏功能

左室肥厚的诊断标准

高血压左心室肥厚的早期检出及治疗

血管紧张素II受体偏向性激动剂通过缝隙连接蛋白43改善自发高血压大鼠心室肥厚

讨论1

醛固酮导致心肌损伤的超声影像评估

高血压与冠状动脉慢血流

高血压心脏病及心衰的早期预防和治疗

评估老年ACS患者PCI术后出血及血栓风险的真实世界研究：BRIC-ACS试验的亚组分析

讨论2

高尿酸血症与心血管疾病的风险与管理

CKD患者的血压、血糖和血脂管理

高血压合并CKD的诊治要点

140/90 mmHg以上是否需要做风险评估？

围绕醛固酮的新药

围绕利钠肽系统的新药

SGLT2抑制剂排盐

瘦素受体缺乏阻碍代谢手术减重效益的研究

非奈利酮通过抑制NOX4/NLRP3通路改善盐敏感大鼠高血压肾损伤

讨论

诊室外血压的管理之路

可穿戴血压创新探索之路

规范血压测量需要8分钟，建立血压测量中心是必由之路

应用听诊法同步对示波法血压计进行准确性校验的真实世界研究

血压波动的医源性因素

讨论

从病例出发探讨伪嗜咯细胞瘤的特征及诊治

从青年高血压病例看PPGL的临床诊疗思维

肾动脉狭窄性高血压--治疗决策带来的思考（一例自体肾移植患者长期随访）

由病例看单基因低肾素高血压的临床诊治

从病例看中段主动脉受累疾病与高血压

讨论

老年高血压降压目标研究的再分析

衰弱老年高血压患者的血压管理

老年人特殊血压表型的管理要点

老年高血压与认知功能障碍的诊疗

以年龄划分老年人降压目标的依据是否充分？

老年高血压个体化治疗中的低血压问题

老年人血压变异的机制与管理

血压变异的叠加是老年高血压患者干预的重要靶点

老年共病患者血压管理的策略与安全性

高龄老年人的降压治疗应重点关注降压达标还是安全性？

新策略指导高血压管理的新实践

高血压患者运动风险的评估及管理

高血压及其他心血管危险因素综合管理的挑战与对策

正常高值血压”与“血压升高”或“高血压前期”的涵义及管理策略是否一致？

基于数据驱动的老年高血压心血管风险评估及分级管理的新模式

信息化建设在基层高血压管理中的作用

智慧化手段助力高血压诊疗：前景和进展

AI在高血压诊疗管理中的现状与展望

讨论

高血压合并慢性冠脉综合征的特点及治疗

左室舒张功能障碍与心血管预后

老年高血压合并认知障碍患者的大脑注意网络功能分析

老年高血压合并冠心病患者心血管代谢性共病的流行趋势及预后研究

讨论

山东省城乡15年心血管疾病随访研究进展

中国高血压防控初现成效？（山东德州高血压测量数据分析报告）

基层未控制高血压调查及防控策略建议

北京社区老年人高血压亚型与全因及心脑血管死亡风险的关联研究

基于限制性立方样条函数分析中老年血脂异常人群体质量指数与高血压患病的关系

讨论

代谢性心脏病学管理新模式

心血管-肾脏-代谢（CKM）综合征的临床管理

基于疑难病例看血压与心肾代谢

内脏脂肪促进卒中的发生发展

肥胖相关性高血压患者运动心肺功能的研究

讨论

高血压合并房颤的治疗

社区老年人群房颤患病与管理现状的城乡差异

PERK介导的内质网应激促进肥胖相关房颤发生

整合 GWAS 和 eQTL 数据的孟德尔随机化揭示了 N6-甲基腺苷甲基化与高血压及其相关心血管疾病相关

MiR-29b-3p 通过靶向 Wnt2b 调节心房成纤维细胞纤维化

讨论

从EVER-SPIRIT到HAO-Target，高血压研究任重道远

ESPRIT研究

讨论1

开滦研究

ANTI-MASK研究

IMPACT研究

讨论2

立位性低血压合并卧位性高血压的识别、治疗及最新进展

中主动脉综合症导致严重肾血管性高血压的诊治研究进展

高血压治疗中-药物性低血压的诊断与鉴别诊断

主动脉瓣膜疾病TAVR术中的血流动力学改变

心脏淀粉样变和低血压

讨论

再论原发性醛固酮增多症的诊断

非标化下原醛症筛查与诊疗的新思路

亚临床原醛：诊疗关口前移？

女性原发性醛固酮综合征

不同方法测得的大学生人群ARR比较

讨论

国家心力衰竭指南2023应用与讨论

中国心力衰竭不同阶段人群流行病学特征和预后

病例分享：肥胖心力衰竭患者的治疗

心力衰竭的超声心动图诊断

心力衰竭的血压管理

讨论

继发性高血压筛查重点及治疗

高血压合并低血钾

继发性高血压的治疗决策与思考

去肾交感神经术重塑室旁核与主动脉生物钟系统促进非杓型高血压向杓型转化的机制研究

讨论

肥胖高血压人群的运动干预

老年患者的运动干预

运动对高血压影响的研究进展

高血压患者运动的安全性评估

讨论

基因检测在高血压的病因诊断中的作用

降压药物基因组学研究

高血压相关疾病基因检测及解读策略

嗜铬细胞瘤儿茶酚胺合成机制的单细胞转录组研究

原发性高血压患者SCNN1G基因多态性分析

不同泛素化特征与高血压的相关性：一项孟德尔随机化研究

肿瘤肾脏病学发病机制与诊疗新进展

阿普昔腾坦可改善阿帕替尼通过ET-1/RhoA/ROCK信号通路所致的血压升高

血管内皮生长因子抑制剂所致高血压的诊治

高血压合并肿瘤患者的血压管理

无共病成年人共病状况轨迹对胃肠道癌症发病风险的影响

讨论

醛固酮拮抗剂会成为高血压的一线药物吗？

重视经导管血管介入技术在高血压诊治中的应用现状与展望

小分子醛固酮合成酶抑制剂

肾上腺动脉栓塞对原醛症患者肾功能的影响

讨论1

双重内皮素受体阻断剂

小干扰RNA药物

讨论2

“原发性醛固酮增多症病例集”项目启动仪式

高血压病因学分型诊治

继发性高血压诊治流程

高血压患者原醛筛查诊治流程及ChinaPAPS研究新进展

医共体模式下原醛症的诊治经验

2024年五月血压测量月（MMM）总结

Opening Remark

Digital Health and Education Interventions for Hypertension Management

Female Sexual Dysfunction with Hypertension

Exercise prescription for hypertension patients

Mechanisms of Testosterone-induced Cardiac Hypertrophy in postmenopausal women with hypertension

Prevalence and survival risk of kidney function status among hypertensive adults

Discussion and Closing

Renovascular Hypertension

Highlight of Renal Denervation clinical trials in China-more active researches are needed

Vascular aging and Cardiovascular 1.5-level Prevention

Chronological outcomes of renal function after adrenalectomy in patients with primary aldosteronism across age groups

Comparison of three approaches for adrenal venous sampling in patients with primary aldosteronism

Dissection and Aneurysm in Patients With Renal Artery Fibromuscular Dysplasia

Neutrophil-to-lymphocyte Ratio can predict the Long-term Prognosis of Patients with Primary Aldosteronism

Opening Remark

International Society of Hypertension Capacity Building Network: overview and how to get involved

Research Progress on Repeatability Verification of Oral Salt Tolerance Experiments

Factors associated with poor sleep quality among patients with hypertension in a primary care clinic - A cross-sectional study

Influence of Echocardiographic Criteria on the Prevalence and Prognostic Implication of Left Ventricular Hypertrophy in Community Populations: A Nationwide Population-based Study

Vaccines Targeting Interleukin-1 Receptor Type I Ameliorates Inflammatory Infiltration and Fibrosis as well as Reducing Susceptibility to Atrial Fibrillation after Myocardial Infarction in Mice

Characteristics of Plasma Metabolism in Hypertension and Diabetes Mellitus and Its Correlation with Aldosterone

讨论总结

Opening and Introduction

Association of Body Weight Time in Target Range with the Risk of Major Adverse Cardiovascular Event Outcomes in Patients With Overweight/Obesity, Combined Hypertension, and Type 2 Diabetes Mellitus

Mechanisms of Empagliflozin in Improving Hypertensive Cardiac Remodeling through Sympathetic Nervous System

Interaction between family history of hypertension and dyslipidemia on the risk of hypertension

Digital Profiling of Positive Responders to Antihypertensive Medications: A Step Forward to Personalized Therapy in Hypertension

Nonobese young females with PCOS are at high risk for long-term cardiovascular disease

Childhood Hypertension, Transition to Normotension in Adulthood, and Subclinical Cardiovascular Outcomes in Adults: A 36-Year Prospective Cohort Study

Improved cardiovascular risk prediction using echocardiography in primary prevention for community populations with hypertension

Olaparib reduces the high blood pressure caused by VEGF inhibitors

The association of triglyceride-glucose index, triglyceride to high‐density lipoprotein cholesterol ratio and related parameters with prehypertension and hypertension over 45 years old: a cross-sectional study

Knowledge, Attitudes, and Practices (KAP) of Salt Intake among Hypertensives and Normotensives of a Malaysian University Campus

Discussion and Closing

The effect and mechanism of BMP9 in promoting hypertension

bone marrow mesenchymal stem cells (BMSCs) improved hypertension via mediating FoxO signaling pathway

The mechanism by which apatinib combined with camrelizumab induces elevated blood pressure may involve the activation of NOTCH1 pathway

SENP3 Regulates Hypertension-Induced Abdominal Aortic Aneurysm via De-SUMOylation of CTH

The ATRQβ-001 vaccine prevents atrial fibrillation and limits atrial remodeling in spontaneously hypertensive rats

NR4A1 Deficiency Exacerbates Carotid Vulnerable Paque by activating integrated stress response via Targeting Bcat1

G Protein-Coupled Receptor 35 Attenuates Diabetic Cardiomyopathy Through Optical Atrophy 1-Dependent Antioxidant Response

Identification and Validation of Immune-Related Genes in Acute Myocardial Infarction Using Machine Learning and Weighted Gene Co-expression Network Analysis

24h ambulatory pulse pressure variation and pulse pressure index: predictive value for coronary artery disease

The relationship between nocturnal systolic blood pressure and estimated glomerular filtration rate in patients of heart failure with reduced ejection fraction

Long-term Impact of COVID-19 Infection on Ambulatory Blood Pressure Profiles in Hypertensive Patients: A Before-and-After Observational Study

Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension (AZAF)

The association between systolic blood pressure target and cardiovascular-related events in hypertension and coronary heart disease patients: a single-center retrospective cohort study

Knowledge, Attitude and Practice of Home Blood Pressure Monitoring (HBPM) among Patients with Hypertension in Putrajaya, Malaysia

Efficacy and Safety of Allisartan Isoproxil/Amlodipine in Patients with Essential Hypertension Uncontrolled by Amlodipine: A Phase III, Multicenter, Double-Blind, Parallel-Group, Randomized Controlled Trial

Morning blood pressure and bedtime blood pressure were significant correlates of nocturnal hypertension in patients with hypertension

In-hospital Systolic Blood Pressure Lowering Patterns and Risk of Rehospitalization for Angina in Patients with Hypertension and Coronary Artery Disease

CORRELATION BETWEEN CORONARY SLOW FLOW AND NOCTURNAL BLOOD PRESSURE IN HYPERTENSIVE PATIENTS

Chronic Pain and hs-CRP: Key Indicators for Assessing Cardiovascular Risk in Middle-Aged and Elderly Populations and Enhancing Machine Learning Applications

Calibration of 24-Hour Urinary Sodium Excretion Estimates from Fasting Morning Urine in Chinese Populations: A Comparative Analysis of Two Calibration Models and A Locally Developed Model

Impact of the COVID-19 Pandemic on Blood Pressure Variability in Hypertensive Patients: A Retrospective Analysis

Prevalence and clustering trends association of modifiable cardiovascular disease risk factors and ASCVD risk change in ethnic areas of the southwest China plateau: progressively increasing sex disparity

Nonlinear Association between Weight-adjusted Waist Index and Hypertension in Chinese Middle-aged and Older Adults: A Cross-Sectional and Longitudinal Analysis Based on CHARLS

Associations between Socioeconomic Status, Life’s Essential 8, and Cardiovascular Diseases in Chinese Hypertensive Patients from Remote Areas

Smoking, alcohol intake increase the stroke risk in anxious individuals: observational and fraction Mendelian randomization analyses

Cost-Effectiveness of Treatment in Adults with Blood Pressure of 130–139/80–89 mmHg and High Cardiovascular Risk in China: a modelling study

Associations between lifestyle behaviors and physical, psychological, and cognitive multimorbidity in elderly hypertensive patients: a population-based observational study

Association of pulse pressure index with mortality in patients with hypertension: results from NHANES 1999–2018

Association between Admission Hyperglycemia with In-Hospital Mortality Rate in Patients with Hypertension and Acute Aortic Dissection

Quantifying the association of Life's Crucial 9 with cardiovascular diseases among elderly hypertensive patients in remote areas

A comparative study of sackubactril valsartan sodium and amlodipine besylate on vascular remodeling in patients with hypertension

Long-term ozone exposure increased the risk of mortality in sepsis patients

Development and Validation of the Arterial Damage Index: A Comprehensive Evaluation of Arterial Condition

Stenting improves cardiovascular clinical outcomes in patients with middle aortic syndrome caused by aortoarteritis: Long-term results

The Net Clinical Benefit of Fondaparinux vs LMWH in Chinese Non-ST-Segment Elevation Acute Coronary Syndrome Patients: the REFOCAS Nonrandomized Controlled Trial

Development and validation of a risk prediction model for placental abruption in patients with preeclampsia

Development and validation of a risk prediction model for postpartum hemorrhage in patients with hypertensive disorders of pregnancy

Effect and safety of PCSK9 inhibitor in-hospital use on blood lipid levels in ACS patients: a GRADE-assessed systematic review and meta-analysis

Impact of Obstructive Sleep Apnea on Muscle Quantity and Quality in Non-Elderly Hypertensive Patients: An Exploratory Study Using Chest CT and Metabolomics

Association between plasma aldosterone levels and target organ damage in hypertensive patients with obesity

Clinical Characteristics of Isolated Renal Branch Artery Stenosis in Patients with Renal Artery Fibromuscular Dysplasia

Development of a diagnostic model for pre‑washout screening of primary aldosteronism

Comparison of the efficacy and safety of low-dose antihypertensive combinations in hypertensive patients: a systematic review and network meta-analysis

Recurrence of primary aldosteronism 20 years after surgery:a case report

Research Progress on Monogenic Hypertension

Myocardial fibrosis-related characteristics in primary aldosteronism

IMPROVEMENT OF COGNITIVE FUNCTION IN HEART FAILURE ATIENTS BY SGLT2 INHIBITORS—CLINICAL ADVANCES, MECHANISMS, AND FUTURE PERSPECTIVES

Predictive Value of the Perivascular Fat Attenuation Index for MACE in Young People Suspected of CAD

Trend of Hypertension-related Chronic Kidney Disease and its attributable Risk Factors in China: Insights from GBD 2021

Joint Association of Overweight/Obesity and Serum Aldosterone with Systemic Inflammation in Patients with Essential Hypertension

Comparison between triglyceride glucose index and homoeostasis model assessment of insulin resistance in their associations with vascular injury：Danyang Study

Mineralocorticoid receptor regulates vascular damage by inducing autophagy in mice with obesity and hypertension

Serum N-Terminal Pro-B-Type Natriuretic Peptide Is Associated With Insulin Resistance in Chinese: Danyang Study

Impact of Obesity on Blood Pressure Variability in Hypertensive Children

The Association between Lifestyles and Elevated Blood Pressure among Primary and Secondary School Students in Wuhan

Analysis of the characteristics of CPET in essential hypertensive patients with overweight and obesity

欢迎致辞

开幕致辞

开幕致辞

开幕致辞

开拓创新，积极进取，为实现50%高血压控制率而努力奋斗

2024 ESC高血压管理指南更新要点

血压测量和高血压诊断的当前问题和未来前景

开场致辞

高血压患者血压管理新趋势 ：国内外新版高血压指南引发的思考

长期血压管理的新指标：TTR与BPV共同助力长期血压管理

降压达标的新内涵：24小时血压控制

会议讨论（蔡安平主持）

指南针项目总结暨2025指南针项目三期启动

会议总结

开场致辞

起始小剂量A+C联合治疗方案在高血压治疗中的优势

会议讨论

会议总结

超强降压 易触即达--药物创新结构带来超强临床获益

高血压研究进展--AT1受体反向激动作用

会议讨论&总结

特邀嘉宾致辞

会议致辞

从2024中国高血压防治指南解读ARNI新一类降压地位

siRNA降脂药助力ASCVD患者LDL-C达标

会议讨论

会议总结

2024ESC高血压指南解读

中国高血压防治指南（2024年修订版）概要解读

1.新版中欧指南(2024 ESC、ESH、中国高血压防治指南)最大的变化和亮点是什么？

2.与2024中国高血压防治指南在降压策略方面（诊室外血压监测、起始降压治疗阈值、降压目标值等）有何不同？

3.各指南对于老年高血压患者的管理有何不同？未来治疗目标是否会下调？

4.噻嗪样利尿剂为基础的SPC有哪些临床优势？噻嗪样利尿剂与噻嗪型利尿剂有何不同？

会议总结

高血压儿童的筛查与诊断流程：中、美、欧标准比较

高血压贯穿全生命周期：关注儿童青少年高血压

中美儿童和青少年高血压患病率及其与身体成分的关系

讨论

开场致辞

认识 RDN：Symplicity降压治疗的科学原理与循证基础

理解RDN：从中国高血压防治指南（2024 年修订版）看 Symplicity降压治疗的全程管理

Trick or Treat：谁是 Symplicity 降压治疗的合适患者？

实践RDN：论高血压学科建设在 RDN 全程管理中的作用

会议总结

开场致辞

强降压，早联合，筑高血压防治新防线

小剂量、多品种的联合是高血压治疗的一种出路

开场致辞

从坎地氢噻专家共识看降压与靶器官保护

会议讨论

会议总结

主持人开场

嘉宾致辞

最新共识看高血压患者血压血脂综合管理及临床实践

从最新国内外高血压指南看β受体阻滞剂的地位和价值

探索高血压患者心肾代谢综合管理

从典型病例看高血压患者的“糖心肾"共管

会议讨论&总结

中药干预对高血压进展影响的社区队列研究

从新指南看中医药在高血压防治中的应用：需求、证据和展望

什么是现阶段一线降压中药?

中医药在高血压中的应用

讨论

开场致辞

中西融合治疗高血压新证据

基层心血管病综合管理实践指南2024解读

会议讨论&总结

开场致辞

新理念，心前景—GLP-1RA在T2D患者中的心血管-肾脏-代谢获益

问答和讨论

新进展，心获益—体重管理药物的心血管获益新证据

问答和讨论

会议总结

主席致辞

主席致辞

开通CTO病变正向，逆向，ADR策略转换

脉冲场消融临床进展

《中国心力衰竭诊断和治疗指南2024》更新要点解读

心肺运动试验在心血管疾病中的应用

心脏重症相关高血压的管理

讨论与总结

指南的多样性何去何从

从最新指南看高血压精准诊疗

讨论1

从心血管事件链看高血压分期管理

不同血压表型的临床管理

追根溯源，血压的分级应参考何时测量的数值？

讨论2

人工智能赋能柯氏音法血压精准测量

高血压的精准测量和血压类型

数字疗法治疗高血压的评价、困难和远景

讨论1

数字化慢病管理实践

健康数据驱动的队列研究（动态血压测量）

基于移动健康技术的职业人群心血管病风险干预

HIREM-DB：用于高血压、高血糖、高血脂及高尿酸综合研究的集成数据库平台

讨论2

高血压中枢机制研究进展

肾动脉周围神经分布及血压调节

代谢性高血压的交感机制与干预

讨论

RDN从临床试验走向临床实践

高血压合并症与RDN

RDN适宜人群和围手术期规范管理

RDN治疗高血压的优势及局限性

讨论

新指南，新思路-从2024中国指南更新共话高血压患者的优化管理方案

降压药物的减药应从哪些维度考量？

各类降压药物不良反应特点及其相应处理对策

再评β受体阻滞剂的降压地位

沙库巴曲缬沙坦钠与苯磺酸氨氯地平对高血压患者血管重构的对比研究

讨论

特发性醛固酮增多症是否应该做AVS？

非ACTH刺激法，微导管超选法以及ACTH刺激法三法联合可以提高AVS的成功率和准确率

促肾上腺皮质激素刺激在非同步肾上腺静脉取血的价值

使用上肢静脉途径联合股静脉途径进行同步双侧肾上腺静脉取血可以提高AVS的成功率

讨论1

醛固酮分泌不当综合症

原发性醛固酮综合征的诊疗困惑

讨论2

2023 OSAS相关性高血压的中国专家共识

OSAS的非手术治疗及疗效评价

高原-心衰-陈氏呼吸的思考

OSAS的外科治疗及评价

讨论

Association of Total Mortality and Cardiovascular Endpoints with the Timing of the First and Second Systolic Peak of the Aortic Pulse Wave

Hypertensive Retinopathy Research: From Clinical Trials to Practice

An Outcome-Driven Threshold for Pulse Pressure Amplification

Adventitia in Arterial Remodeling: Clinical Evidence and Translational Insights

Sensitive Detection of Single Nucleotide Polymorphisms Genotyping by Conjugated Polymers for Personalized Medicine of Hypertension

Blood Pressure Lowering Efficacy Of Sacubitril/allisartan Versus Olmesartan In Chinese Patients With Primary Hypertension Nighttime Non-dipping

silencing Mas-related G protein-coupled receptor member D (MrgD) improved hypertension via mediating Cav1.2-CamkII gamma axis

How to Manage Hypertension in 2025: International Consensus?

Salt Reduction in Asia: Current strategies, Barriers and Opportunities

Investigation of Blood Pressure Variability from Seasonal to Personal Levels: Approach from a Data Scientist

Association of Baseline Cumulative LDL-C Exposure with Hemorrhagic and Ischemic Events in ACS Patients Within One Year Post-Discharge

Weight-adjusted waist index may predict hypertension plus hyperuricemia

Bone Mineral Loss and Risk of Atrial Fibrillation: A Multicohort Study

Opening Remark

Does increased arterial stiffness precede the development of hypertension?

Hypertension in the young

Hypertension and Atrial Fibrillation: a Dangerous Combination

The Effect of Remnant Cholesterol and Blood Pressure on the Risk of New-onset Non-alcoholic Fatty Liver Disease: A 10-year Prospective Cohort Study from China

Association of Inflammatory Markers with Cardiovascular Diseases and Mortality in Populations with Different Stages of Cardiovascular-Kidney-Metabolic Syndrome

总结讨论

Nocturnal blood pressure monitoring. Methodological and Clinical Aspects

What have we learned from the recent clinical trials of hypertension?

Disordered gut Microbiome and alterations in metabolic patterns are associated with hypertensive Left Ventricular Hypertrophy

Atlas of Cell Repertoire within Neointimal Lesions Shows Metabolic Alterations in Hypertensive Rats

Hypertension awareness, treatment, control, and prognosis: Insights from the sub-cohort of China PEACE Million Persons Project

Characteristics of Hypertension Subtypes Across Different Age Groups

讨论

脂肪细胞褐变对冠状动脉内皮细胞的影响

巨噬细胞相关细胞因子与睡眠呼吸暂停之间的因果关系：一项双样本双向孟德尔随机化研究

巨噬细胞Setd1a介导心肌梗死后纤维化的形成及其表观遗传学机制的研究

不同免疫细胞的表型在高血压中的作用进展

中青年高血压患者血清生物学标志物的探究

养血清脑丸联合氨氯地平治疗原发性高血压（血虚肝旺证）的疗效观察

贝前列素钠联合沙库巴曲缬沙坦钠片对原发性高血压合并早期肾功能不全的疗效及安全性分析

原发性高血压患者心肺运动试验相关指标特征及其对预后预测价值

中国城乡社区老年高血压病患者健康生活行为调查：基于中国健康与养老追踪调查2015至2020年队列研究

高血压运动处方的知信行调查

345例正常高值血压患者空腹血糖升高的患病现状及相关因素分析

脂质沉积指数、甘油三酯血糖指数与H型高血压及冠心病的相关性分析

急性冠脉综合征患者血清RC与TGI、HbA1c、hs-CRP的相关性分析

临界高血压患者血尿酸升高的临床现状及影响因素分析

体重调整指数与高血压左心室肥厚的相关性

再谈肥胖诱导的高血压

MAFB转录激活SRC-1调控PVAT褐变的分子机制

内皮素受体拮抗剂在阿帕替尼经NOTCH3信号通路所致高血压治疗的相关研究

高血压合并射血分数保留的心力衰竭患者夜间收缩压与心肾损害之间的关系

腹腔镜下肾动脉外膜交感神经射频消融术治疗难治性高血压的临床研究

肾动脉微循环阻力对肾动脉去交感神经术治疗高血压疗效的评估效果

sST2在原发性高血压患者血清中表达规律及辅助诊断价值

食管早癌患者血压与癌灶病变特征之间的关系

线粒体相关蛋白与高血压及其所致心肌肥厚的因果关系：一项双样本孟德尔随机化分析

高血压伴阻塞性睡眠呼吸暂停患者左心室舒张末期容积对心血管结局事件的影响

靶向1-磷酸鞘氨醇受体2的新型疫苗防治小鼠腹主动脉瘤的作用及机制研究

SENP3通过去SUMO化CTH 调控高血压诱导的腹主动脉瘤

非阻塞性冠状动脉疾病患者动态血压升高与运动性高血压相关性研究

为什么血透患者的血压控制目标为SBP<160 mmHg?

老年高血压的目标值确定

高血压合并冠心病患者收缩压靶目标与结局风险的单中心回顾性队列研究

指南推荐130/80mmHg的目标值，证据是否充分？

辩论讨论

中国人群肥胖的发展趋势

代谢性高血压的机制与干预

高血压合并高脂血症的治疗

糖尿病性高血压的综合控制

儿童高尿酸血症在肥胖合并高血压的中间效应

残粒胆固醇及其变异性与新发高血压的相关性：一项十年的前瞻性队列研究

讨论

闭幕致辞

青年研究者奖颁奖仪式

最佳英文口头发言奖颁奖仪式

最佳英文壁报奖颁奖仪式

最佳中文壁报奖颁奖仪式

闭幕总结

从儿童到中年期心血管危险因素演变与靶器官损伤的关系

儿童24h动态血压昼夜节律与心血管靶器官损害的关联

心肺耐力与儿童原发性高血压的相关性研究

讨论1

中青年高血压的管理

青少年单纯收缩期高血压及其健康结局

醛固酮水平与中青年原发性高血压患者血压的关联

讨论2

高危高血压人群的抗血小板治疗

心血管病高危人群“三高”共管干预研究

甘油三酯葡萄糖指数对非糖尿病高血压患者心血管疾病风险的影响--一项为期10年的前瞻性队列研究

SGLT2抑制剂对高血压合并糖尿病的心血管保护作用

高血压合并肥胖：双重挑战 有效策略

老年冠心病合并高血压患者临床特征及预后的性别差异

讨论

肾上腺消融治疗原醛症的问题与展望

低肾素型高血压的诊治

原发性醛固酮增多症的经皮选择性肾上腺动脉栓塞治疗

自发醛固酮增多症与高血压

讨论

低钠盐应用的安全性与适用人群

中国低钠盐推广应用指南解读

中国北方敬老院人群长期食用富钾低钠盐对死亡事件的影响—中国盐试验

昆明地区不同盐敏感性高血压患者肠道菌群组成与血压相关性研究

讨论1

高血压患者生活方式干预的效果及依从性

基于肠-肝轴探讨代谢相关脂肪性肝病患者的肠道菌群特征及低碳水饮食的干预研究

讨论2

海南岛生态环境、长寿要素及其高血压特点分析

低氧环境对血压的影响

藏区人群血压管理

职业人群高血压相关危险因素聚集特点及健康管理效果评估

环境暴露物对儿童高血压影响的效应与机制研究

血压及血压变异与气候因素的关系：MMM2020中国数据

讨论

主动脉缩窄术后合并妊娠１例

病例讨论1

肾、输尿管多发结石伴肾盂积水致继发性高血压1例

病例讨论2

73岁男性高血压、腹主动脉支架置入术史合并急性腹痛

病例讨论3

总结讨论

Opening Remark

HOPE Asia Home BP-Centered Approach including BP Variability

Role of potassium and salt substitution in the management of Hypertension

Metabolomic Features Associated with Hospitalization of Heart Failure in Patients with Hypertension

Analysis of the relationship between the vascular overload index and left ventricular hypertrophy

Temporal trends in mortality of hypertensive heart disease attributable to high sodium intake，1990 to 2021：: An age-period-cohort analysis for the Global Burden of Disease 2021 study

Discussion and Closing

Opening Remark

Self-Measured Home Blood Pressure in Japan

China ABPM & HBPM Studies

The impact of amlodipine-based antihypertensive therapy on blood pressure time in target range in Chinese adults with hypertension[代]

Measuring Only Sitting Blood Pressure Without Considering Supine Blood Pressure Underestimates Cardiovascular Risk in Older Adults： A 6.4-Year Prospective Study from Northern Shanghai

The Predictive Value of Ambulatory Blood Pressure Monitoring in Pediatric Hypertension Progression: A Retrospective Study

Study on the Preventive and Therapeutic Effects of ROCK2 Inhibitors on Myocardial Injury in Apatinib-Induced Hypertensive Mice

讨论总结